175 related articles for article (PubMed ID: 30227240)
1. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles.
Hu Y; Li M; Zhang M; Jin Y
Int J Pharm; 2018 Nov; 551(1-2):212-222. PubMed ID: 30227240
[TBL] [Abstract][Full Text] [Related]
2. Inhalable oridonin-loaded poly(lactic-
Zhu L; Li M; Liu X; Du L; Jin Y
Acta Pharm Sin B; 2017 Jan; 7(1):80-90. PubMed ID: 28119812
[TBL] [Abstract][Full Text] [Related]
3. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles.
El-Sherbiny IM; Smyth HD
Mol Pharm; 2012 Feb; 9(2):269-80. PubMed ID: 22136259
[TBL] [Abstract][Full Text] [Related]
4. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
5. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
[TBL] [Abstract][Full Text] [Related]
6. [Effect of curcumin on the expression of collagen type I protein and transforming growth factor-beta1 mRNA in pulmonary fibrosis rats].
Chen B; Zhang DP; Gao W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 May; 26(5):257-61. PubMed ID: 18727865
[TBL] [Abstract][Full Text] [Related]
7. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
8. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
[TBL] [Abstract][Full Text] [Related]
9. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly.
Durairaj P; Venkatesan S; Narayanan V; Babu M
Mol Biol Rep; 2021 Dec; 48(12):7775-7785. PubMed ID: 34643929
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
[TBL] [Abstract][Full Text] [Related]
12. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
13. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation.
Rawat A; Majumder QH; Ahsan F
J Control Release; 2008 Jun; 128(3):224-32. PubMed ID: 18471921
[TBL] [Abstract][Full Text] [Related]
14. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
[TBL] [Abstract][Full Text] [Related]
16. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.
Thomas C; Gupta V; Ahsan F
Pharm Res; 2010 May; 27(5):905-19. PubMed ID: 20232117
[TBL] [Abstract][Full Text] [Related]
17. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis.
Skurikhin E; Madonov P; Pershina O; Ermakova N; Pakhomova A; Widera D; Pan E; Zhukova M; Sandrikina L; Artamonov A; Dygai A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070506
[TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery.
Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM
Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]